Emerging studies suggest Retatrutide , a dual stimulator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , appears to provide a notable development for weight management . Initial patient investigations have shown impressive losses in abdominal fat , potentially exceeding other weight-loss medications . Despite th